Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesNeuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Fiebigera W et al. – The occurrence of NETs/undifferentiated neuroendocrine carcinomas following organ transplantation appears to be rare, with an incidence comparable with the normal population. Our data suggest a highly aggressive course with a dismal prognosis and unresponsiveness to chemotherapy.
Methods- Retrospectively analyzed patients undergoing organ transplantation between 1985 and 2001 in order to assess the frequency and clinical course of NETs in organ transplant recipients
- 3,190 organ transplant recipients with sufficient clinical data identified (2,521 kidney and 669 heart transplants)
- In total, 161/3,190 patients (5%) developed malignancies, with 6 of them being classified as NETs (0.18%)
- Interestingly, all 6 patients diagnosed with undifferentiated neuroendocrine carcinomas, while no indolent NETs seen
- 4 of these patients had undergone renal, 1 patient heart and 1 patient both heart and renal transplantation
- All 6 patients given chemotherapy, but none of them responded, as all patients showed disease progression after median of 3 cycles of chemotherapy (range 1-4) with the median survival being 4.8 months (range 2-11)
Related Articles
Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center
Medical Oncology, 11/19/09
Relevance Score: 67%
Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09
Relevance Score: 67%
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Relevance Score: 66%
High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09
Relevance Score: 66%
Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09
Relevance Score: 66%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients
Acta Diabetologia, 02/09/10
The development of a sleep apnea screening program in Romanian type 2 diabetic patients: a pilot study
Acta Diabetologia, 02/09/10
The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma
Journal of Clinical Neuroscience, 02/05/10
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pearls: Primary Brain Tumors
Seminars in Neurology, 02/09/10
Intraoperative stimulation techniques for functional pathway preservation and glioma resection
Neurosurgical Focus, 02/09/10
Parotid and Temporal Bone Resection for Skull Base Malignancies: Outcome
Skull Base, 02/08/10
Article Search
Sponsor
Sponsor